Detalhe da pesquisa
1.
A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens.
J Urol
; 204(2): 289-295, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068483
2.
Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
BJU Int
; 125(4): 525-530, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863617
3.
Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship.
World J Urol
; 38(3): 741-746, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087122
4.
The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Cancer
; 125(7): 1050-1059, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561782
5.
A Systematic Review on Artificial Intelligence Evaluating Metastatic Prostatic Cancer and Lymph Nodes on PSMA PET Scans.
Cancers (Basel)
; 16(3)2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339239
6.
A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?
Life (Basel)
; 14(1)2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255691
7.
Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrest.
Can Urol Assoc J
; 15(4): E199-E204, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007182
8.
A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide.
Urology
; 153: 147-155, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33592224
9.
Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
Urol Oncol
; 39(7): 431.e1-431.e8, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495118
10.
Utility of digital rectal examination in a population with prostate cancer treated with active surveillance.
Can Urol Assoc J
; 14(9): E453-E457, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32223879
11.
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Mol Metab
; 25: 119-130, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023626
12.
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces.
Can Urol Assoc J
; 12(10): 328-336, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29688882
13.
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes.
Eur Urol Open Sci
; 21: 1-4, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337460
14.
Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update.
ANZ J Surg
; 78(11): 977-81, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18959696